Advertisement
Advertisement
Sino Biopharmaceutical
TOPIC
 / company

Sino Biopharmaceutical

Sino Biopharmaceutical
Sino Biopharmaceutical
Sino Biopharmaceutical develops, manufactures and markets pharmaceuticals, biopharmaceuticals and Chinese medicines. It offers products to treat conditions ranging from hepatitis to respiratory and digestive diseases. It is a subsidiary of Thailand's Charoen Pokphand Group.
Chairman / President
Theresa Tse
CEO / Managing Director
Tse, Eric S Y
CFO / Finance Director
Li Chunling
Industry
Pharmaceuticals
Website
sinobiopharm.com
Headquarters address
Unit 09, 41/F, Office Tower, Convention Plaza, 1 Harbour Road, Wanchai, Hong Kong
Stock Code
SEHK:1177
Year founded
2000
LATEST China Science NEWS
MORE China Science NEWS
Biomedicine: Companies

China biotech deals hit record as innovative drugs draw global interest

Deals reach US$60 billion in first quarter after analysts say Chinese biotech firms have shown substantial technological advancements.

China investors energise Hong Kong biotech stocks. Is foreign money missing out?

Global funds, from BlackRock to Temasek, back China’s largest biotech firms

Global institutional investors have built up sizeable positions in firms including Innovent, 3SBio, WuXi Biologics, Jiangsu Hengrui, Akeso and BeOne.

Advertisement
Advertisement
Advertisement
Help preserve 120 years of quality journalism.
SUPPORT NOW
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement